Literature DB >> 26396635

Brain MRI, Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT Findings in a Patient with Wilson Disease: A Case Report.

Seungyoo Kim1, In Uk Song1, Yong An Chung2, Eun Kyung Choi2, Jin Kyoung Oh2.   

Abstract

A 34-year-old female had experienced head and hand tremors with a dystonic component for 8 months. Brain MRI showed T2 high signal intensity in the periaqueductal region, dorsal midbrain and dorsal upper pons. No abnormal uptake was noted on Tc-99m HMPAO SPECT or F-18 FP-CIT PET/CT. Wilson disease was diagnosed according to the 2008 consensus guideline from the American Association for the Study of Liver Disease and 2012 guideline from the European Association for the Study of the Liver. This case demonstrates T2 signal change in the basal ganglia, excluding the putamen, in a Wilson disease patient with relatively severe clinical findings, but normal Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT.

Entities:  

Keywords:  F-18 FP-CIT PET/CT; MRI; Tc-99m HMPAO SPECT; Wilson disease

Year:  2014        PMID: 26396635      PMCID: PMC4571669          DOI: 10.1007/s13139-014-0290-4

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  10 in total

1.  EASL Clinical Practice Guidelines: Wilson's disease.

Authors: 
Journal:  J Hepatol       Date:  2012-03       Impact factor: 25.083

2.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

3.  Cranial MR findings in Wilson's disease.

Authors:  I Saatci; M Topcu; F F Baltaoglu; G Köse; K Yalaz; Y Renda; A Besim
Journal:  Acta Radiol       Date:  1997-03       Impact factor: 1.990

4.  Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.

Authors:  Henryk Barthel; Wieland Hermann; Regine Kluge; Swen Hesse; David R Collingridge; Armin Wagner; Osama Sabri
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

5.  Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]ss-CIT and high-resolution SPET.

Authors:  H Barthel; D Sorger; H J Kühn; A Wagner; R Kluge; W Hermann
Journal:  Eur J Nucl Med       Date:  2001-11

6.  Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI.

Authors:  G Schlaug; H Hefter; V Engelbrecht; T Kuwert; S Arnold; G Stöcklin; R J Seitz
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

7.  Wilson disease: findings at MR imaging and CT of the brain with clinical correlation.

Authors:  H N van Wassenaer-van Hall; A G van den Heuvel; A Algra; T U Hoogenraad; W P Mali
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

8.  Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.

Authors:  A Pujol; J Pujol; F Graus; A Rimola; J Peri; J M Mercader; J C García-Pagan; J Bosch; J Rodés; E Tolosa
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease.

Authors:  Mario Piga; Alessandra Murru; Loredana Satta; Alessandra Serra; Alessandro Sias; Gianluigi Loi; Francesco Marrosu; Luigi Demelia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-08       Impact factor: 9.236

10.  Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.

Authors:  B Jeon; J M Kim; J M Jeong; K M Kim; Y S Chang; D S Lee; M C Lee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

  10 in total
  1 in total

1.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.